Thyroid Cancer with Dr Lori Wirth
Dr Lori Wirth from the Massachusetts General Hospital in Boston discusses the latest clinical data and ongoing investigations on targeted therapeutic approaches for the management of RET-altered and NTRK fusion-positive thyroid cancers. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayThyroid21/Issue1).
